» Articles » PMID: 17369837

CD8(+) T-cell Responses to Adeno-associated Virus Capsid in Humans

Overview
Journal Nat Med
Date 2007 Mar 21
PMID 17369837
Citations 384
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatic adeno-associated virus (AAV)-serotype 2 mediated gene transfer results in transgene product expression that is sustained in experimental animals but not in human subjects. We hypothesize that this is caused by rejection of transduced hepatocytes by AAV capsid-specific memory CD8(+) T cells reactivated by AAV vectors. Here we show that healthy subjects carry AAV capsid-specific CD8(+) T cells and that AAV-mediated gene transfer results in their expansion. No such expansion occurs in mice after AAV-mediated gene transfer. In addition, we show that AAV-2 induced human T cells proliferate upon exposure to alternate AAV serotypes, indicating that other serotypes are unlikely to evade capsid-specific immune responses.

Citing Articles

Consecutive Affinity and Ion-Exchange Chromatography for AAV9 Vectors Purification.

Duzenli O, Aslanidi G Biomedicines. 2025; 13(2).

PMID: 40002774 PMC: 11852678. DOI: 10.3390/biomedicines13020361.


The combination of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables multi-administration to liver.

Gan C, Leng M, Liu Y, Zheng Z, He S, Qiao W Mol Ther Methods Clin Dev. 2025; 33(1):101399.

PMID: 39897641 PMC: 11787516. DOI: 10.1016/j.omtm.2024.101399.


Polyfunctional T cells and unique cytokine clusters imprint the anti rAAV2/rAAV9 vector immune response.

Holtkamp S, Lagoda F, Lister A, Harish P, Kleymann U, Pesch T Front Immunol. 2024; 15:1450524.

PMID: 39654900 PMC: 11625739. DOI: 10.3389/fimmu.2024.1450524.


Recent Advances in Designing Adeno-Associated Virus-Based Vaccines Against Viral Infections.

Mnyandu N, Jacobs R, Arbuthnot P, Maepa M Pharmaceutics. 2024; 16(11).

PMID: 39598484 PMC: 11597783. DOI: 10.3390/pharmaceutics16111360.


mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating Cancer.

Chen K, Ernst P, Sarkar A, Kim S, Si Y, Varadkar T Cancer Res. 2024; 84(23):4049-4065.

PMID: 39288077 PMC: 11609628. DOI: 10.1158/0008-5472.CAN-24-0984.